These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28344483)

  • 1. Pharmacovigilance system in Saudi Arabia.
    Alshammari TM; Alshakka M; Aljadhey H
    Saudi Pharm J; 2017 Mar; 25(3):299-305. PubMed ID: 28344483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct healthcare professional communications: A quantitative assessment study.
    Alsaleh H; Alshammari TM
    Pharmacol Res Perspect; 2021 May; 9(3):e00763. PubMed ID: 33929085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
    Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
    Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status, and future prospects of pharmaco-epidemiology and post-marketing surveillance in Saudi Arabia: A review of literature.
    El-Metwally A
    Saudi Pharm J; 2018 Jul; 26(5):629-633. PubMed ID: 29989016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance Perception and Knowledge Among Pharmacists and Interns in Saudi Arabia.
    Alshayban D; Mahmoud MA; Islam MA; Alshammari S; Alsulaiman D
    Risk Manag Healthc Policy; 2020; 13():55-61. PubMed ID: 32158290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of adverse drug reactions (ADRs) in Saudi Arabia.
    Bin Yousef N; Yenugadhati N; Alqahtani N; Alshahrani A; Alshahrani M; Al Jeraisy M; Badri M
    Saudi Pharm J; 2022 Jan; 30(1):8-13. PubMed ID: 35145342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
    Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
    BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saudi Vigilance Program: Challenges and lessons learned.
    Alharf A; Alqahtani N; Saeed G; Alshahrani A; Alshahrani M; Aljasser N; Alquwaizani M; Bawazir S
    Saudi Pharm J; 2018 Mar; 26(3):388-395. PubMed ID: 29556130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
    Sales I; Aljadhey H; Albogami Y; Mahmoud MA
    Saudi Pharm J; 2017 Sep; 25(6):868-872. PubMed ID: 28951672
    [No Abstract]   [Full Text] [Related]  

  • 15. EU's new pharmacovigilance legislation: considerations for biosimilars.
    Calvo B; Zuñiga L
    Drug Saf; 2014 Jan; 37(1):9-18. PubMed ID: 24190573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-authorization pharmacovigilance for hemophilia in Europe and the USA: Independence and transparency are keys.
    Peyvandi F; Garagiola I; Mannucci PM
    Blood Rev; 2021 Sep; 49():100828. PubMed ID: 33810898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University.
    Bepari A; Assiri RA; AlYahya MA; AlGhamdi SJ; AlGhamdi AM; AlOnazi AA
    Saudi Pharm J; 2020 Jul; 28(7):828-836. PubMed ID: 32647484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia.
    Alshabi AM; Shaikh MAK; Shaikh IA; Alkahtani SA; Aljadaan A
    Saudi Pharm J; 2022 Jul; 30(7):1018-1026. PubMed ID: 35903528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.